How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
MarketWatch· Jaimy Lee· Aug 5, 2026 · 4:52 PM
The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 12 hours ago
This could be the worst year ever for Nike’s stock, with sales set to fall further
The company has faced struggles in China and in its sneaker business.
MarketWatch
marketsabout 12 hours ago
Here’s who’s joining the S&P 500 in the index’s latest shakeup
Twilio gets the nod, as current component Warner Bros Discovery is due to merger with Paramount.
MarketWatch
marketsabout 14 hours ago
The hidden silver lining of high interest rates: safer, cheaper retirement income
Annuity payout rates are closely tied to interest rates
MarketWatch